The US may use “trade tools” to retaliate against European ESG regulations that affect American companies, said Howard ...

ORIC Pharmaceuticals (NASDAQ:ORIC – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Guggenheim in a research report issued to clients and investors on Monday,Benzinga reports.

Equities research analysts at Cantor Fitzgerald decreased their FY2025 EPS estimates for Kimball Electronics in a research note issued on Thursday, February 6th. Cantor Fitzgerald analyst D. Soderberg ...

Fintel reports that on February 11, 2025, Cantor Fitzgerald initiated coverage of Domo (NasdaqGM:DOMO) with a Overweight ...

Will the Senate GOP confirm controversial picks like Tulsi Gabbard and RFK Jr.? Here’s the hearings schedule and list of ...

Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...

In a report released yesterday, Matthew Prisco from Cantor Fitzgerald maintained a Buy rating on Onto Innovation (ONTO – Research Report), with ...

It’s not that the Trump administration is anti-Goldman Sachs, sources say, but rather there just isn’t as much talent to take ...

LKQ Corporation (LKQ) filed suit against Robert Rutledge, its former plant manager, in the U.S. District Court for the Northern District ...

Cantor Fitzgerald analyst Colin Canfield initiated coverage of Amentum (AMTM) with a Neutral rating and $25 price target Maximize Your ...